IP Library Granted Patent US 6,916,660
Granted Patent B2
US 6,916,660 · App. 10/437,362 · Granted Jul 12, 2005

Fluorescent sensor compounds for detecting saccharides

Assignee: North Carolina State University
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 6,916,660
App. No.
10/437,362
Granted
Jul 12, 2005
Kind
B2
Abstract

Fluorescent sensor compounds having the formula: wherein L is selected from the group consisting of alkyl, alkylene, aryl, cycloalkyl, alkoxy, aryloxy, arylalkyl, and arylalkyloxyl; each m, m′, n, n′, p, and p′ is independently an integer from 0 to 4, inclusive; and each R 1 , R′ 1 , R 2 , R′ 2 , R 3 and R′ 3 is independently selected from the group consisting of hydrogen, alkyl, alkylene, aryl, cycloalkyl, alkoxy, aryloxy, arylalkyl, arylalkyloxyl, halo, substituted and unsubstituted amino, and substituted and unsubstituted thiol, are useful for the selective detection of saccharides such as glucose and sialyl Lewis X. The compounds find particular use in detecting saccharides in biological samples, and in detecting cancer cells that express cell surface polysaccharides such as sialyl Lewis X.

Claims (47)

1. A fluorescent sensor compound having the formula:

wherein L is selected from the group consisting of alkyl, alkylene, aryl, cycloalkyl, alkoxy, aryloxy, arylalkyl, and arylalkyloxyl;

each m, m′, n, n′, p, and p′ is independently an integer from 0 to 4, inclusive; and

each R 1 , R′ 1 , R 2 , R′ 2 , R 3 and R′ 3 is independently selected from the group consisting of hydrogen, alkyl, alkylene, aryl, cycloalkyl, alkoxy, aryloxy, arylalkyl, arylalkyloxyl, halo, substituted and unsubstituted amino, and substituted and unsubstituted thiol.

2. The compound according to claim 1 , wherein L is selected from the group consisting of C 2 to C 20 alkyl.

3. The compound according to claim 1 , wherein L is aryl.

4. The compound according to claim 1 , wherein L is selected from the group consisting of:

5. The compound according to claim 1 , wherein L is selected from the group consisting of:

6. The compound according to claim 1 , wherein m, m′, n, n′, p, and p′ are each zero and L is:

7. The compound according to claim 1 , wherein m, m′, n, n′, p, and p′ are each zero and L is:

8. The compound according to claim 1 , wherein the compound selectively binds a saccharide.

9. The compound according to claim 8 , wherein the saccharide is a monosaccharide.

10. The compound according to claim 9 , wherein the monosaccharide is glucose.

11. The compound according to claim 8 , wherein the saccharide is a polysaccharide.

12. The compound according to claim 11 , wherein the polysaccharide is a cell-surface polysaccharide.

13. The compound according to claim 11 , wherein the polysaccharide is sialyl Lewis X (sLex).

14. A method of detecting glucose in a biological sample, comprising contacting a biological sample with a fluorescent sensor compound having the formula:

wherein L is selected from the group consisting of alkyl, alkylene, aryl, cycloalkyl, alkoxy, aryloxy, arylalkyl, and arylalkyloxyl;

each m, m′, n, n′, p, and p′ is independently an integer from 0 to 4, inclusive;

each R 1 , R′ 1 , R 2 , R′ 2 , R 3 and R′ 3 is independently selected from the group consisting of hydrogen, alkyl, alkylene, aryl, cycloalkyl, alkoxy, aryloxy, arylalkyl, arylalkyloxyl, halo, substituted and unsubstituted amino, and substituted and unsubstituted thiol; and

detecting the presence or absence of fluorescence in the sample,

wherein the presence of fluorescence indicates the presence of glucose in the sample.

15. The method according to claim 14 , further comprising

measuring the amount of fluorescence in the sample; and

correlating the amount of fluorescence in the sample with a concentration of glucose in the sample.

16. The method according to claim 14 , wherein m, m′, n, n′, p, and p′ are each zero and L is:

17. The method according to claim 14 , wherein the fluorescent sensor compound is provided in an implantable sensor device.

18. A method of detecting sialyl Lewis X in a biological sample, comprising contacting a biological sample with a fluorescent sensor compound having a formula:

wherein L is selected from the group consisting of alkyl, alkylene, aryl, cycloalkyl, alkoxy, aryloxy, arylalkyl, and arylalkyloxyl;

each m, m′, n, n′, p, and p′ is independently an integer from 0 to 4, inclusive; and

each R 1 , R′ 1 , R 2 , R′ 2 , R 3 and R′ 3 is independently selected from the group consisting of hydrogen, alkyl, alkylene, aryl, cycloalkyl, alkoxy, aryloxy, arylalkyl, arylalkyloxyl, halo, substituted and unsubstituted amino, and substituted and unsubstituted thiol; and

detecting the presence or absence of fluorescence in the sample, wherein the presence of fluorescence indicates the presence of sialyl Lewis X in the sample.

19. The method according to claim 18 , further comprising:

measuring the amount of fluorescence in the sample; and

correlating the amount of fluorescence in the sample with a concentration of sialyl Lewis X in the sample.

20. The method according to claim 18 , wherein m, m′, n, n′, p, and p′ are each zero and L is:

21. A method of detecting cancer cells that express sialyl Lewis X in a biological sample, comprising contacting a biological sample with a fluorescent sensor compound of the formula:

wherein L is selected from the group consisting of alkyl, alkylene, aryl, cycloalkyl, alkoxy, aryloxy, arylalkyl, and arylalkyloxyl;

each m, m′, n, n′, p, and p′ is independently an integer from 0 to 4, inclusive; and

each R 1 , R′ 1 , R 2 , R′ 2 , R 3 and R′ 3 is independently selected from the group consisting of hydrogen, alkyl, alkylene, aryl, cycloalkyl, alkoxy, aryloxy, arylalkyl, arylalkyloxyl, halo, substituted and unsubstituted amino, and substituted and unsubstituted thiol; and

detecting the presence or absence of fluorescence in the sample, wherein the presence of fluorescence indicates the presence of cancerous in the sample.

22. The method according to claim 21 , further comprising:

measuring the amount of fluorescence in the sample; and

correlating the amount of fluorescence in the sample with the amount of cancerous cells in the sample.

23. The method according to claim 21 , wherein m, m′, n, n′, p, and p′ are each zero and L is:

24. The method according to claim 21 , wherein the cancer cells are carcinoma cells.

25. The method according to claim 21 , wherein the cancer cells are hepatocellular carcinoma cells.

Assignments (2)
CONFIRMATORY LICENSE Recorded Apr 24, 2017
From: NORTH CAROLINA STATE UNIVERSITY RALEIGH
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 042320/0745 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 8, 2003
From: WANG, BINGE; WESTON, BRENT; YANG, WENQIAN
To: NORTH CAROLINA STATE UNIVERSITY
Reel/Frame 013859/0609 →
Continuity (2)
Provisional Application 6038051900 · May 14, 2002
Related Publication 20040048390A1 · Mar 11, 2004